Krystal Biotech
KRYS
KRYS
282 hedge funds and large institutions have $5.15B invested in Krystal Biotech in 2024 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 107 increasing their positions, 89 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2% less capital invested
Capital invested by funds: $5.24B → $5.15B (-$91.1M)
1.46% less ownership
Funds ownership: 99.89% → 98.44% (-1.5%)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Holders
282
Holding in Top 10
6
Calls
$89.7M
Puts
$67.2M
Top Buyers
| 1 | +$42.4M | |
| 2 | +$34.4M | |
| 3 | +$22.3M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$21.8M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$16.6M |
Top Sellers
| 1 | -$38.4M | |
| 2 | -$29.5M | |
| 3 | -$22M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$20.4M |
| 5 |
Jennison Associates
New York
|
-$20.1M |